So — that pig-to-hu­man trans­plant; Po­ten­tial di­a­betes cure reach­es pa­tient; Ac­cused MIT sci­en­tist lash­es back; and more

Wel­come back to End­points Week­ly, your re­view of the week’s top bio­phar­ma head­lines. Want this in your in­box every Sat­ur­day morn­ing? Cur­rent End­points read­ers can vis­it their read­er pro­file to add End­points Week­ly. New to End­points? Sign up here.

We’re in­cred­i­bly ex­cit­ed to wel­come Beth Bu­lik, sea­soned phar­ma mar­ket­ing re­porter, to the team. You can find much of her work in our new Mar­ket­ing chan­nel — and in her week­ly newslet­ter, End­points Phar­maRx, which will launch in ear­ly No­vem­ber. Add it to your sub­scrip­tions here.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

Venture & Research Associate

Alexandria Real Estate Equities

San Francisco, CA, USA